Why is Growth More Difficult to Achieve for Biopharmaceutical Latecomer Firms? Evidence from Taiwan
Authors:
- Mei-Chih HuMHMei-Chih Hu
- Wen-Ching HsuWHWen-Ching Hsu
- Ching-Yan WuCWChing-Yan Wu
Open Access
- 2 May 2018
- journal article
- research article
- Published by SAGE Publications in Science, Technology and Society
- Vol. 23 (3) , 388-417
Abstract
This study examines why the growth of biopharmaceutical firms in latecomer countries such as Taiwan has been slower than that of information and communication technology (ICT) firms. Unlike prior studies which have focused on the industry-level driving forces, this study offers a firm-level perspective to examine factors driving industry growth. By utilising the DEcision-MAking Trial and Evaluation Laboratory (DEMATEL) method, we analyse data collected in questionnaires with the top managers of biopharmaceutical and ICT firms in Taiwan, both public and non-public. We then compared and contrasted our empirical findings to capture theoretical and practical insights. Our empirical results demonstrate that the entrepreneurial activities of Taiwan’s biopharmaceutical firms are weak in terms of adaptation to external institutions and the utilisation of resources while the primary drivers of growth in Taiwan’s biopharmaceutical firms are rather (internal) institutional factors than resource-based factors, especially in the emerging and early growth stages. We conclude that the challenge for the latecomers lies on the institutional entrepreneurship to enable and affect the circulation of strategic resources so as to bring the firms onto the growth and mature stages.Keywords
This publication has 34 references indexed in Scilit:
- Fast-Follower Industrial Dynamics: The Case of Taiwan's Emergent Solar Photovoltaic IndustryIndustry and Innovation, 2011
- Success factors for innovation management in networks of small and medium enterprisesR&D Management, 2011
- An innovation management approach for renewable energy deployment—the case of solar photovoltaic (PV) technologyEnergy Policy, 2009
- What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEsBiotechnology Letters, 2008
- An institution-based view of international business strategy: a focus on emerging economiesJournal of International Business Studies, 2008
- Reconfiguring the innovation policy portfolios for Taiwan's SIP Mall industryTechnovation, 2007
- Evaluating intertwined effects in e-learning programs: A novel hybrid MCDM model based on factor analysis and DEMATELExpert Systems with Applications, 2007
- Linking the technological regime to the technological catch-up: analyzing Korea and Taiwan using the US patent dataIndustrial and Corporate Change, 2006
- The Relational View: Cooperative Strategy and Sources of Interorganizational Competitive AdvantageAcademy of Management Review, 1998
- The Effects of R&D, Foreign Technology Purchase, and Domestic and International Spillovers on Productivity in Indian FirmsReview of Economics and Statistics, 1996